AbbVie Inc.
Close on Nov 2, 2026Market cap $510.41BP/E 81.6Yield 2.30%
AbbVie Creon (pancrelipase) — Worldwide net revenues by Year
Creon (pancrelipase) — Worldwide net revenues ($M) ($M)
AbbVie Creon (pancrelipase) — Worldwide net revenues: $1,512M in FY2025, up 9.3% from a year earlier. That is the highest of the 11 years on record here.
Where the FY2025 figure comes from
Source: Form 10-K (filed 2026-02-20) ↗
Reported in Form 10-Q / 10-K Segment & Revenue Disaggregation Note & Form 8-K Key Product Revenues.
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Creon (pancrelipase) — Worldwide net revenues ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 1,512 | +9.3% | Form 10-K (filed 2026-02-20) ↗ |
| FY2024 | Dec 31, 2024 | 1,383 | +9.1% | Form 10-K (filed 2026-02-20) ↗ |
| FY2023 | Dec 31, 2023 | 1,268 | -0.8% | Form 10-K (filed 2026-02-20) ↗ |
| FY2022 | Dec 31, 2022 | 1,278 | +7.3% | Form 10-K (filed 2025-02-14) ↗ |
| FY2021 | Dec 31, 2021 | 1,191 | +6.9% | Form 10-K (filed 2024-02-20) ↗ |
| FY2020 | Dec 31, 2020 | 1,114 | +7.0% | Form 10-K (filed 2023-02-17) ↗ |
| FY2019 | Dec 31, 2019 | 1,041 | +12.2% | Form 10-K (filed 2022-02-18) ↗ |
| FY2018 | Dec 31, 2018 | 928 | +11.7% | Form 10-K (filed 2021-02-19) ↗ |
| FY2017 | Dec 31, 2017 | 831 | +13.8% | Form 10-K (filed 2018-02-16) ↗ |
| FY2016 | Dec 31, 2016 | 730 | +15.5% | Form 10-K (filed 2018-02-16) ↗ |
| FY2015 | Dec 31, 2015 | 632 | – | Form 10-K (filed 2018-02-16) ↗ |
Breakdown
What makes up creon (pancrelipase) — Worldwide net revenues
Cite this data
StockData. (2026). AbbVie Creon (pancrelipase) — Worldwide net revenues ($M), annual FY2015–FY2025 [Data set]. Compiled from AbbVie SEC filings and investor materials. https://stockdatahq.com/stocks/abbv/kpis/creon-ww
See every metric in the AbbVie KPI table. Data updated Oct 26, 2026.